Ongoing Phase 1b human challenge study with oral, direct-acting protease inhibitor is designed to demonstrate ...
Gilead Sciences Inc. recently disclosed details on the work that led to the discovery of elunonavir (GS-1156), an unboosted HIV protease inhibitor currently in phase I studies.
The role of cytoreductive nephrectomy (CN) in the immune checkpoint inhibitor (ICI) era of metastatic renal cell carcinoma (mRCC): A systematic review and individual patient data (IPD) meta-analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results